Foresite Capital Opportunity Management V, LLC 13F Holdings · last filed Q3 2022
Foresite Capital Opportunity Management V, LLC reported 9 securities worth $33.31M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: PRDS (29.04%), THRX (16.71%), IRON (11.99%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PRDS | Pardes Biosciences Inc | $9.7M | 29.04% | 5.2M | Hold |
| 2 | THRX | Theseus Pharmaceuticals, Inc. | $5.6M | 16.71% | 959,275 | Hold |
| 3 | IRON | Gemini Therapeutics, Inc. | $4.0M | 11.99% | 2.4M | Hold |
| 4 | CMPX | Compass Therapeutics, Inc. | $3.5M | 10.64% | 1.6M | Hold |
| 5 | KNTE | Kinnate Biopharma Inc. | $3.5M | 10.46% | 291,667 | Hold |
| 6 | ACET | Adicet Bio, Inc. | $2.4M | 7.26% | 170,000 | Hold |
| 7 | QSI | Quantum-Si Incorporated | $1.7M | 5.23% | 633,626 | Hold |
| 8 | HIMS | Hims & Hers Health, Inc. | $1.7M | 5.13% | 306,431 | Hold |
| 9 | ENTA | Enanta Pharmaceuticals, Inc. | $1.2M | 3.54% | 22,750 | Hold |
Source: SEC Form 13F filings · as of 2022-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR